Page 49 - Cardiac testing for coronary artery disease in potential kidney transplant recipients
P. 49

Ferreira 2007  (Continued)



                 Index and comparator tests     Dobutamine/atropine stress echocardiography
                                                  • Progressive doses of dobutamine 5, 10, 20, 30 and 40 µg/kg/min, with an
                                                increment every 3 minutes. In cases when the final objective of the evaluation had not
                                                been reached, 0.25 mg/min atropine was added simultaneously after the third minute
                                                of the infusion of 40 µg/kg/min of dobutamine, up to a total maximum cumulative
                                                dose of 1 mg. The test was considered diagnostic when either 85% of the maximum for
                                                age or echocardiographic signs of myocardial ischaemia was reached. The test was
                                                considered non-diagnostic when there were inadequate images for the analysis (lack of
                                                definition on ≥ 2 myocardial segments); inability to reach target stress, and premature
                                                test withdrawal due to limiting side effects without attaining one of the test aims.
                                                  • Definitions guiding interpretation were: Normal result defined as uniform
                                                increase of systolic movement and thickening of the left ventricular wall and
                                                consequent reduction of its final systolic volume (global hyperdynamic response); a
                                                positive result for myocardial ischaemia was defined as a new alteration of the reversible
                                                segmental contractility or worsening of a pre-existing segmental alteration, in ≥ 2
                                                contiguous myocardial segments.

                 Follow-up

                 Notes

                 Table of Methodological Quality

                 Item                           Authors’ judgement             Description

                 Representative spectrum?       Yes                            Patients with ESKD who were kidney
                 All tests                                                     transplant candidates undergoing cardiac
                                                                               evaluation. Examinations performed one
                                                                               day after haemodialysis

                 Acceptable reference standard?  Yes                           Coronary angiography with a reference
                 All tests                                                     standard threshold of ≥ 70% stenosis

                 Acceptable delay between tests?  Yes                          Not longer than 2 months.
                 All tests

                 Partial verification avoided?   Yes                            All participants who underwent an index
                 All tests                                                     test also received the reference standard test

                 Differential verification avoided?  Yes                        This was not an issue in this study. Disease
                 All tests                                                     status (CAD) is diagnosed only through
                                                                               coronary angiography

                 Incorporation avoided?         Yes                            This was not an issue in this study. Disease
                 All tests                                                     status (CAD) is diagnosed only through
                                                                               coronary angiography





                Cardiac testing for coronary artery disease in potential kidney transplant recipients (Review)  47
                Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
   44   45   46   47   48   49   50   51   52   53   54